News · Ophthalmology
406 stories
Aug 18, 26Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
Aug 18, 26STAT+: Nonprofit health system raked in $1.1 billion this year from stake in medical billing firm
Aug 18, 26STAT+: Pharmalittle: We’re reading about a setback for Eyepoint, a win for Amylyx, and more
Aug 17, 26STAT+: Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition
Aug 17, 26STAT+: Eyepoint study results for vision treatment disappoint, but company still sees promise
Aug 14, 26‘We’re not afraid of competition’: BioCryst CEO sets out strategy after scrapping internal discovery